Statins in neurological disorders: an overview and update.
about
Data gaps limit the translational potential of preclinical research.Statin Use and the Risk of Parkinson's Disease: An Updated Meta-AnalysisPharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Statins Reduce the Risks of Relapse to Addiction in RatsTemporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patientsPravastatin Chronic Treatment Sensitizes Hypercholesterolemic Mice Muscle to Mitochondrial Permeability Transition: Protection by Creatine or Coenzyme Q10.The renin-angiotensin system: a possible new target for depression.Exploring novel AEDs from drugs used for treatment of non-epileptic disorders.Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation.Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis.Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design.The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive Impairment.Antioxidant effect of simvastatin throught oxidative imbalance caused by lisdexamfetamine dimesylate.Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport.The Therapeutic Potential of Metformin in Neurodegenerative Diseases
P2860
Q31035567-97EE2939-6D7B-42E4-8458-6B6FF170E3ACQ35971467-A51AAD83-A3EA-4BB1-93E3-BE3083ABC9C4Q36353053-C60E0CC7-1BCF-482B-9C92-D8CC50CCD667Q36799030-DAC36A3A-6002-4686-AE13-88AB7A021F87Q36817489-5B14719E-5B41-4166-BFD9-7822EC47DCA9Q37737599-B99CCC7B-B2F5-4F1C-AA14-C017B4CDC6F3Q38651269-20FA28BE-72D6-4558-B399-96F3DBF1970EQ38787286-737E582A-24D8-4EF0-926E-7D5FAD657D0DQ38809645-AB31EC1C-C9EC-4D90-B798-CBE98247BC9BQ38820490-D1F93B14-30AC-4E87-9046-359051198FD6Q38928422-7E076712-1AD9-42D4-A65C-BA0A230BB8A7Q42266154-0C4B8E0B-63C6-42C7-83D7-E0959FA8077DQ43098045-8D29F71E-550B-4E61-8D6D-77F03BA18A00Q48910881-C1919554-F947-47AC-B99F-46F914E2188CQ50301194-D2BE7C45-BA33-41C7-9F43-D908CA13395CQ55099778-5C75352A-19D0-4877-8F5D-2BAF48D3272FQ57175337-DD412F35-91D7-450A-8143-72FEF514E5B2
P2860
Statins in neurological disorders: an overview and update.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Statins in neurological disorders: an overview and update.
@en
type
label
Statins in neurological disorders: an overview and update.
@en
prefLabel
Statins in neurological disorders: an overview and update.
@en
P2093
P1476
Statins in neurological disorders: an overview and update
@en
P2093
Chiara Laezza
Giuseppe Marasco
Maria Chiara Proto
Patrizia Gazzerro
P356
10.1016/J.PHRS.2014.06.007
P577
2014-06-19T00:00:00Z